Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple- antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI Tae-Hyun Yang, Han-Young Jin, Kyu-Nam Choi, Ungjeong Do, Hyung Jun Kim, Sang-Ryul Chung, Jeong-Sook Seo, Jae-Sik Jang, Dae- Kyeong Kim, Dong-Soo Kim International Journal of Cardiology Volume 168, Issue 1, Pages 207-211 (September 2013) DOI: 10.1016/j.ijcard.2012.09.093 Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Schematic of study design. International Journal of Cardiology 2013 168, 207-211DOI: (10.1016/j.ijcard.2012.09.093) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
Fig. 2 Serial change of P2Y12 reaction unit values. International Journal of Cardiology 2013 168, 207-211DOI: (10.1016/j.ijcard.2012.09.093) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
Fig. 3 P2Y12 reaction unit values at discharge. International Journal of Cardiology 2013 168, 207-211DOI: (10.1016/j.ijcard.2012.09.093) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions
Fig. 4 Individual P2Y12 reaction unit values according to treatment. Lines represent medians. International Journal of Cardiology 2013 168, 207-211DOI: (10.1016/j.ijcard.2012.09.093) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions